Exhibit 10.1


 


(ted)
Employment Agreement


 


This
EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of December 11, 2017, by and between Helios And
Matheson Analytics Inc., a Delaware corporation (the “Company”), and Theodore Farnsworth (“Executive”).


 


WHEREAS,
the Company recognizes that the Executive has had and is expected to continue to have a critical and essential role in guiding
the Company and in developing the Company’s business;


 


WHEREAS,
the Executive is expected to make major contributions to the stability, growth and financial strength of the Company;


 


WHEREAS,
the Company has determined that appropriate arrangements should be taken to encourage the continued attention and dedication of
the Executive to his assigned duties without distraction;


 


WHEREAS,
in consideration of the Executive’s employment with the Company, the Company desires to provide the Executive with certain
compensation and benefits as set forth in this Agreement;


 


WHEREAS,
as of the date of this Agreement, the Company wishes to continue Executive’s service as a Chief Executive Officer under
the terms of an employment agreement on the terms set forth herein, which shall supersede all previous agreements regarding Executive’s
employment by the Company; and


 


WHEREAS,
the Executive desires to be employed by the Company on the terms contained in this Agreement.


 


NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:


 


1. Position
and Duties. 


 


(a) The
Executive shall serve as the Chief Executive Officer of the Company reporting to the Company’s Board of Directors (the “Board”).
The Executive shall primarily work out of 444 Brickell Avenue, Miami, Florida 33131 (the “Executive’s Office”).


 


(b) The
Company agrees to propose to the shareholders of the Company at each appropriate meeting of such shareholders during the Term
and any Renewal Term, the election and reelection of the Executive as a member of the Board. Provided the Executive is elected
by the shareholders to the Board, the Executive shall be appointed Chairman of the Board. In addition, without further compensation,
the Executive shall serve as a director or officer of one or more of the Company’s subsidiaries or affiliates if so elected
or appointed from time to time. 


 


(c) The
Executive shall have such duties, authority and responsibilities as are consistent with the role of Chief Executive Officer and
as may be set forth in the Bylaws of the Company. For purposes of the applicability of the Company compensation plans to the Executive,
Executive shall be considered an “employee.” Executive shall devote a substantial amount of his business time to the
performance of his duties hereunder, but such requirement shall not prevent Executive from (i) serving as a member of the board
of directors of unaffiliated companies, (ii) serving on civic, charitable, educational, religious, public interest or public service
boards, (iii) managing the Executive’s personal and family investments, and (iv) engaging in or having an ownership interest
in other businesses. In addition, the Executive has disclosed, in writing, to the Company his involvement in entities and investments
other than the Company (collectively, the “Outside Activities”). The Company shall permit the Executive to
continue to engage in the Outside Activities provided that the Executive agrees to disclose to the Board, in writing, any actual
or potential conflict of interest arising out of any such Outside Activity and no such Outside Activity materially interferes
with Executive’s ability to perform his responsibilities hereunder.


 






     


     


    

 


2. Term.
This Agreement and Executive’s employment hereunder shall be for an initial term of five (5) years commencing on the
date hereof (the “Effective Date”) and ending on the fifth anniversary of the Effective Date (the “Expiration
Date”), unless terminated earlier by the Company or the Executive pursuant to Section 4 of this Agreement (the “Term”).
Thereafter, this Agreement shall automatically be renewed and the Term shall be extended for additional consecutive terms of 1
year (each a “Renewal Term”), unless such renewal is objected to by either the Company or the Executive upon
90 days written notice prior to the commencement of the next Renewal Term. In the event of renewal, the last day of each Renewal
Term shall be deemed the new Expiration Date.


 


3. Compensation
and Related Matters.


 


(a) Base
Salary. The Executive’s initial annual base salary shall be $325,000, less applicable withholdings (the “Base
Salary”). The Base Salary shall be payable in accordance with the Company’s normal payroll procedures in effect
from time to time. On each anniversary of this Agreement the base salary will increase no less than $15,000 (“minimum”).
The Board shall review the Base Salary annually and may increase the Base Salary more than the minimum, and the term “Base
Salary” shall refer to such increased amount. 


 


(b) Annual
Bonus. For 2017, the Executive shall receive a cash bonus in the amount of $350,000 payable on or before December 29, 2017,
and an award of 53,255 shares of Company common stock, which shall vest in their entirety on February 15, 2019, (the “Principal
Market”), which shall be received by the Executive no later than March 15, 2018. After 2017 and during the Term, the
Executive will receive an annual cash bonus and an annual award of shares of common stock, subject to vesting conditions, in respect
of each full or partial fiscal year of the Company, as well as other cash or equity bonuses, as determined in the sole discretion
of the Board based on its assessment of Company and individual performance in relation to performance targets, a subjective evaluation
of Executive’s performance or such other criteria as may be established by the Board (the “Annual Bonus”).
The Annual Bonus will be paid no later than the 75th day following the end of the fiscal year to which the Annual Bonus
relates. The annual cash target bonus is 25% of the Base Salary and the value of the annual award of shares of Company common
stock, as of the date of the grant, will be equal to 200% of the Base Salary as determined by the closing price of the common
stock on the Principal Market on the date of grant (which shares of common stock shall vest ratably at the end of each of the
six calendar quarters subsequent to the calendar quarter in which the grant is made). Any award of common stock pursuant to this
Agreement shall be subject to the Company’s receipt of all corporate approvals required by applicable law or the rules and
regulation of the Principal Market and the terms of a Restricted Stock Award Agreement between Executive and the Company to be
agreed upon following the execution of this Agreement and prior the issuance of any common stock award to the Executive (each,
an “Award Agreement”). 


 


(c) Milestone
Bonuses. In addition to any other compensation to which the Executive is entitled, upon the Company initially attaining any
of the milestones set forth on Schedule 1 hereof, Executive will be entitled to awards of common stock calculated in accordance
with Schedule 1 hereof. Any such award of common stock shall be subject to the terms of the applicable Award Agreement.


 






    2


     


    




 


(d) Capital
Raise Bonus For Extraordinary Performance in 2017. Upon the execution of this Agreement, the Executive shall become entitled
to receive a one-time bonus of $1,000,000 for his extraordinary efforts above and beyond his duties as the Chief Executive Officer,
specifically with respect to bringing capital sources that have been critical to the Company’s needs in 2017, which shall
be paid to the Executive no later than December 29, 2017. The Executive may, in his sole discretion, subject to the Company’s
and the Executive’s compliance with applicable legal and regulatory requirements, elect to accept unregistered shares of
common stock of the Company in lieu of the cash bonus described above, valued based on the last closing price of the common stock
on Nasdaq preceding the execution of this Agreement. 


 


(e) Long
Term Incentive Plan. The Executive shall be entitled to participate in all bonus or other compensation programs adopted by
the Company and applicable generally to senior executives of the Company.


 


(f) Equity
Incentive Plan. The Executive shall be awarded shares of common stock of the Company, subject to vesting conditions, as set
forth in Exhibit A hereto, subject to the terms of the applicable Award Agreement. Additionally, the Executive shall be
entitled to participate in any and all plans providing for awards of equity or instruments convertible into equity adopted by
the Company and applicable generally to other senior executives of the Company.


 


(g) Business
Expenses. The Company shall promptly reimburse the Executive for all reasonable and necessary business-related expenses incurred
in connection with the performance of the Executive’s duties hereunder in accordance with the policies and procedures then
in effect and established by the Company for its senior executive officers, provided that the Executive furnishes the Company
with all supporting information and documentation relevant to such expenses as the Company may reasonably request. The Executive
is entitled, though not required, to travel first class or business class on all domestic and international flights. If the Executive
leases an apartment in New York City in connection with duties that the Executive is providing to the Company or its affiliates,
the Executive shall provide the Company with a copy of the lease and the Company shall pay the rent directly to the landlord.
In connection with such lease, the Executive shall provide the Company with a schedule of all trips that the Executive makes to
New York City in order to conduct business relating to the Company or its affiliates.


 


(h) Health
Insurance. Executive shall be entitled to participate in any Company health insurance plan on the same terms and conditions
as other Company senior executives are permitted to participate.


 


(i) Life
Insurance. To the extent practicable, the Company shall, during the Term, pay the premiums of a life insurance policy, providing
coverage in the amount of $3,000,000, payable to a beneficiary chosen by Executive, which insures the life of Executive. Executive
shall provide all information and cooperation reasonably necessary to obtain such life insurance policy. 


 


(j) Automobile
Allowance. During the Term, Executive shall receive a monthly automobile allowance in the amount of $750.00 per month for
automobile-related expenses.


 


(k) Other
Benefits. The Executive shall be entitled to participate in all pension, savings and retirement plans, welfare and insurance
plans, practices, policies, programs and perquisites of employment applicable generally to other senior executives of the Company.


 






    3


     


    




 


(l) Vacation.
The Executive shall be entitled to accrue up to 20 paid vacation days in each year, which shall be accrued ratably. The Executive
shall also be entitled to all paid holidays given by the Company to its executives and employees. Any unused vacation days shall
be rolled forward to be used in future years, provided that vacation days shall not accrue further if Executive has 30 accrued
but unused vacation days. 


 


(m) Sick
Days. The Executive shall be entitled to accrue up to 5 paid sick days in each year, which shall be accrued ratably. Any unused
sick days shall be rolled forward to be used in future years, provided that sick days shall not accrue further if Executive has
10 accrued but unused sick days.


 


(n) Withholding.
All amounts payable to the Executive under this Section 3 shall be subject to all required federal, state and local withholding,
payroll and insurance taxes and requirements.


 


4. Termination.



 


(a) Death.
The Executive’s employment hereunder shall terminate upon his death.


 


(b) Disability.
The Company may terminate the Executive’s employment if the Executive becomes subject to a Disability. For purposes of this
Agreement, “Disability” means the Executive is unable to perform the essential functions of his position as
CEO, with or without a reasonable accommodation, for a period of 120 consecutive days or 180 days during any rolling consecutive
12 month period.


 


(c) Termination
by Company for Cause. The Company may terminate the Executive’s employment for Cause. For purposes of this Agreement,
“Cause” means the Executive’s: (i) willful misconduct, gross negligence, fraud, embezzlement
or other material dishonesty with respect to the affairs of the Company or any of its affiliates; (ii) material failure to meet
minimum performance expectations of the Board; (iii) conviction, plea of nolo contendere, guilty plea, or confession to
either a felony or any lesser crime relating to the affairs of the Company or any of its affiliates or of which fraud, embezzlement,
or moral turpitude is a material element; or (iv) a material breach of this Agreement or a breach of a fiduciary duty owed
to the Company, provided that any such breach, if curable, shall not constitute Cause unless the Company has provided the Executive
with (x) written notice of the acts or omissions giving rise to a termination of his employment for Cause; (y) the opportunity
to correct the act or omission within 30 days after receiving the Company’s notice (the “Cure Period”);
and (z) an opportunity to be heard before the Board with the Executive’s counsel present prior to the expiration of the
Cure Period. 


 


(d) Termination
by the Company without Cause. The Company may not terminate the Executive’s employment during any Term or Renewal Term
without Cause. 


 


(e) Termination
by the Executive. The Executive may terminate his employment at any time for any reason other than a Good Reason, upon 30
days prior written notice. 


 


(f) Termination
by the Executive for Good Reason. The Executive may terminate his employment for Good Reason by providing written notice.
For purposes of this Agreement, “Good Reason” means: (i) a material reduction in the Executive’s Base
Salary; (ii) a material diminution in the Executive’s responsibilities as CEO; (iii) the assignment of duties to the Executive
materially inconsistent with his position as CEO; (iv) the requirement that the Executive relocate his primary place of employment
more than 20 miles from Executive’s Office (unless such location is closer to the Executive’s primary residence);
or (v) the Company’s material breach of this Agreement; provided that Good Reason based on a material breach shall exist
only if within 90 days of the Company’s act or omission resulting in a material breach, the Executive notifies the Company
in a writing of the act or omission, the Company fails to correct the act or omission within 30 days after receiving the Executive’s
written notice and the Executive actually terminates his employment within the 30 days following the end of such 30-day cure period.


 






    4


     


    




 


(g) Expiration.
Executive’s employment shall terminate on the Expiration Date.


 


(h) Termination
Date. The “Termination Date” means: (i) if the Executive’s employment is terminated by his death
under Section 4(a), the date of his death; (ii) if the Executive’s employment is terminated on account of his Disability
under Section 4(b), the date on which the Company provides the Executive a written termination notice; (iii) if the Company terminates
the Executive’s employment for Cause under Section 4(c), the date on which the Company provides the Executive a written
termination notice, unless the circumstances giving rise to the termination are subject to the Cure Period, in which case the
date on which the Company provides the Executive a written termination notice following the end of the Cure Period; (iv) if, despite
the restriction against doing so under Section 4(d), the Company terminates the Executive’s employment without Cause under
Section 4(d), 90 days after the date on which the Company provides the Executive a written termination notice; (v) if the Executive
resigns his employment without Good Reason under Section 4(e), 30 days after the date on which the Executive provides the Company
a written termination notice; (vii) if the Executive resigns his employment with Good Reason under Section 4(f), the date on which
the Executive provides the Company a timely written termination notice, except the Termination Date shall be the last day of the
relevant 30-day cure period, if applicable; and (viii) the Expiration Date if the Executive’s employment terminates under
Section 4(g).


 


5. Compensation
upon Termination.


 


(a) Termination
by the Company for Cause; by the Executive without Good Reason; or upon the Expiration Date following the Executive’s election
not to Renew. If the Executive’s employment with the Company is terminated pursuant to Section 4(c), 4(e), or 4(g),
the Company shall pay or provide to the Executive the following amounts through the applicable Termination Date: any earned but
unpaid Base Salary, unpaid expense reimbursements, any earned but unpaid Annual Bonus, and the value of any accrued and unused
vacation days (the “Accrued Obligations”) on or before the time required by law but in no event more than 30
days after the Executive’s Termination Date.


 


(b) Death;
Disability. If the Executive’s employment terminates because of his death as provided in Section 4(a) or because of
a Disability as provided in Section 4(b), then the Executive (or his authorized representative or estate) shall be entitled to
the following: 


 


(i) the
Accrued Obligations earned through the applicable Termination Date (payable on or before the time required by law but in no event
more than 30 days after the applicable Termination Date);


 


(ii) a
pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which the Executive’s termination
occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator
of which is the number of days during the fiscal year of termination that the Executive is employed by the Company and the denominator
of which is 365) payable at the same time bonuses for such year are paid to other senior executives of the Company;


 






    5


     


    

 


(iii) vest
the Executive on the applicable Termination Date for any and all previously granted outstanding equity-incentive awards subject
to time-based vesting criteria as if the Executive continued to provide services to the Company for 12 months following the applicable
Termination Date;


 


(iv) Subject
to the Executive’s or, in the event of his death, his eligible dependents’ timely election of continuation coverage
under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall reimburse
the Executive or his eligible dependents the monthly premium payable to continue his and his eligible dependents’ participation
in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers
the Executive (and the Executive’s eligible dependents) for a period of eighteen (18) months, provided that the Executive
is eligible and remains eligible for COBRA coverage; and provided, further, that in the event that the Executive
obtains other employment that offers group health benefits, such continuation of coverage by the Company shall immediately cease.
 If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims
to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the Health Care and Education Reconciliation
Act of 2010 (collectively, the “Act”) or Section 105(h) of the Internal Revenue Code (the “Code”),
the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent necessary
to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code; and


 


(v) in
the case of a termination due to Disability, in addition to the aforementioned awards, continuation of the Base Salary in effect
on the Termination Date until the earlier of (A) the 12 month anniversary of the Termination Date, and (B) the date Executive
is eligible to commence receiving payments under the Company’s long-term disability policy. If the net compensation from
the Base Salary is greater than the net compensation from the long-term disability policy, the Company, through the 12 month anniversary
of the Termination Date will compensate the Executive’s estate the difference in net compensation.


 


(c) Termination
by the Company without Cause, by the Executive with Good Reason. If the Executive’s employment is terminated by the
Company without Cause despite the restriction against doing so under Section 4(d), or the Executive terminates his employment
for Good Reason as provided in Section 4(f), then the Executive shall, except to the extent Section 5(d) is applicable, be entitled
to the following:


 


(i) the
Accrued Obligations earned through the applicable Termination Date (payable on or before the time required by law but in no event
more than 30 days after the applicable Termination).


 


(ii) severance
in a single lump sum installment in an amount equal to 2x the sum of (A) the Base Salary at the rate in effect on the Termination
Date, plus (B) an amount equal to 2x the maximum Annual Bonus for which the Executive is eligible in the fiscal year in which
the Termination Date occurs, or if, there is no Annual Bonus for which he is eligible in the fiscal year in which the Termination
Date occurs, 2x the Annual Bonus most recently issued to the Executive. The severance is payable no later than 30 days following
the applicable Termination Date.


 


(iii) A
pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which the Executive’s termination
occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator
of which is the number of days during the fiscal year of termination that the Executive is employed by the Company and the denominator
of which is 365) payable at the same time bonuses for such year are paid to other senior executives of the Company.


 






    6


     


    

 


(iv) full
vesting of the Executive in any and all previously granted outstanding equity-based incentive awards subject to time-based vesting
criteria.


 


(v) Subject
to the Executive’s timely election of continuation coverage under COBRA, the Company shall reimburse the Executive the monthly
premium payable to continue his and his eligible dependents’ participation in the Company’s group health plan (to
the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s eligible
dependents) for a period of 18 months, provided that the Executive is eligible and remains eligible for COBRA coverage;
and provided, further, that in the event that the Executive obtains other employment that offers group health benefits,
such continuation of coverage by the Company shall immediately cease.  If the reimbursement of any COBRA premiums would violate
the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Act or Section 105(h) of the Code, the
Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent necessary
to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.


 


(d) Change
of Control: Termination by the Company without Cause, by the Executive with Good Reason. If the Executive’s employment
is terminated by the Company in breach of Section 4(d), or the Executive terminates his employment for Good Reason as provided
in Section 4(f), and such termination occurs (x) at the same time as, or within the 12 month period following, the consummation
of a Change in Control or (y) within the 60 day period prior to the date of a Change in Control where the Change in
Control was under consideration at the time of Executive’s Termination Date, then the Executive shall be entitled to the
following:


 


(i) the
Accrued Obligations earned through the Termination Date (payable on or before the time required by law but in no event more than
30 days after the applicable Termination);


 


(ii) severance
in a single lump sum installment in amount equal to 2x the sum of (A) the Base Salary at the rate in effect on the Termination
Date, plus (B) an amount equal to 2x the maximum Annual Bonus for which the Executive is eligible in the fiscal year in which
the Termination Date occurs, or, if, there is no Annual Bonus for which he is eligible in the fiscal year of the Termination Date,
2x the Annual Bonus most recently issued to the Executive. If either the Base Salary or Annual Bonus has been reduced either 60
days prior to a Change in Control or within 12 months following a Change in Control then severance shall be based upon the previously
highest Base Salary and the highest Annual Bonus previously awarded to the Executive. The severance is payable no later than 30
days following the Termination Date;


 


(iii) a
pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which the Executive’s termination
occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator
of which is the number of days during the fiscal year of termination that the Executive is employed by the Company and the denominator
of which is 365) payable at the same time bonuses for such year are paid to other senior executives of the Company. If there is
no Annual Bonus for which he is eligible in the fiscal year of the Termination Date, then the award shall be based upon a pro
rata share of the Annual Bonus most recently issued to the Executive. If the Annual Bonus has been reduced either 60 days prior
to a Change in Control or within 12 months following a Change in Control then such pro-rata bonus shall be based upon the highest
Annual Bonus previously awarded to the Executive;


 






    7


     


    




 


(iv) full
vesting of the Executive in any and all outstanding previously granted equity-based incentive awards subject to time-based vesting
criteria;


 


(v) subject
to the Executive’s timely election of continuation coverage under COBRA, reimbursement by the Company of the monthly premium
payable to continue the Executive’s and his eligible dependents’ participation in the Company’s group health
plan (to the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s
eligible dependents) for a period of 18 months, provided that the Executive is eligible and remains eligible for COBRA
coverage; and provided, further, that in the event that the Executive obtains other employment that offers group
health benefits, such continuation of coverage by the Company shall immediately cease.  If the reimbursement of any COBRA
premiums would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Act or Section
105(h) of the Code, the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment
to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.


 


(e) Change
of Control: For purposes of Section 5(d), a change of control shall have occurred upon any of the following:


 


(i) any
person or entity or group becoming the beneficial owner, directly or indirectly, of securities of the Company representing more
than 50% of the total voting power of all its then outstanding voting securities; 


 


(ii) a
merger or consolidation of the Company in which its voting securities immediately prior to the merger or consolidation do not
represent, or are not converted into securities that represent, a majority of the voting power of all voting securities of the
surviving entity immediately after the merger or consolidation; 


 


(iii) a
sale of substantially all of the assets of the Company or a liquidation or dissolution of the Company; or 


 


(iv) individuals
who, as of the date of the signing of this Agreement, constitute the Board of Directors (the “Incumbent Board”) cease
for any reason to constitute at least a majority of such Board; provided that any individual who becomes a director of the Company
subsequent to the date of the signing of this Agreement, whose election, or nomination for election by the Company stockholders,
was approved by the vote of at least a majority of the directors then in office shall be deemed a member of the Incumbent Board.



 


(f) 
Consequence of a Change in Control. Notwithstanding the terms of any employee compensation plan, if, as of the date of
a Change in Control, Executive holds equity awards issued under such a plan that are not vested and, if applicable, exercisable,
such equity awards shall become fully vested and, if applicable, exercisable, as of the date of the Change in Control if the acquirer
does not agree to assume or substitute for equivalent equity awards such outstanding unvested equity awards. 


 


(g) No
Mitigation or Offset. In the event of any termination of Executive’s employment hereunder, Executive shall be under
no obligation to seek other employment or otherwise mitigate the obligations of the Company under this Agreement, and there shall
be no offset against any amounts due under this Agreement on account of any remuneration attributable to any subsequent employment
that Executive may obtain.


 






    8


     


    

 


(h) Effect
of Termination on Officer and Board Positions. Any termination of the Executive with respect to the Executive’s standing
as an executive officer or Board Member must expressly designate which such role is subject to termination. The termination of
the Executive as an Officer will not thereby terminate the Executive’s Board status unless the termination so states, in
which event the Executive shall resign his Board position as a condition to receiving any of the payments set forth in this Section
5.


 


6. Section
409A Compliance.


 


(a) All
in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred
by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively
practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year
in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year
shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year. Such
right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.


 


(b) To
the extent that any of the payments or benefits provided for in Section 5(b), (c) or (d) are deemed to constitute non-qualified
deferred compensation benefits subject to Section 409A of the United States Internal Revenue Code (the “Code”),
the following interpretations apply to Section 5: 


 


(i) Any
termination of the Executive’s employment triggering payment of benefits under Section 5(b), (c) or (d) must constitute
a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) before distribution
of such benefits can commence. To the extent that the termination of the Executive’s employment does not constitute a separation
of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) (as the result of further services that
are reasonably anticipated to be provided by the Executive to the Company or any of its parents, subsidiaries or affiliates at
the time the Executive’s employment terminates), any benefits payable under Section 5(b), (c) or (d) that constitute deferred
compensation under Section 409A of the Code shall be delayed until after the date of a subsequent event constituting a separation
of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h). For purposes of clarification, this Section
6(b)(i) shall not cause any forfeiture of benefits on the Executive’s part, but shall only act as a delay until such time
as a “separation from service” occurs.


 


(ii) If
the Executive is a “specified employee” (as that term is used in Section 409A of the Code and regulations and other
guidance issued thereunder) on the date his separation from service becomes effective, any benefits payable under Section 5(b),
(c) or (d) that constitute non-qualified deferred compensation under Section 409A of the Code shall be delayed until the earlier
of (A) the business day following the six-month anniversary of the date his separation from service becomes effective, and (B)
the date of the Executive’s death, but only to the extent necessary to avoid such penalties under Section 409A of the Code.
On the earlier of (A) the business day following the six-month anniversary of the date his separation from service becomes effective,
and (B) the Executive’s death, the Company shall pay the Executive in a lump sum the aggregate value of the non-qualified
deferred compensation that the Company otherwise would have paid the Executive prior to that date under Section 5(b), (c) or (d)
of this Agreement.


 






    9


     


    

 


(iii) It
is intended that each installment of the payments and benefits provided under Section 5(b), (c) or (d) of this Agreement shall
be treated as a separate “payment” for purposes of Section 409A of the Code. 


 


(iv) Neither
the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except
to the extent specifically permitted or required by Section 409A of the Code.


 


7. Excess
Parachute Payments.


 


(a) To
the extent that any payment, benefit or distribution of any type to or for the benefit of the Executive by the Company or any
of its affiliates, whether paid or payable, provided or to be provided, or distributed or distributable pursuant to the terms
of this Agreement or otherwise (including, without limitation, any accelerated vesting of stock options or other equity-based
awards) (collectively, the “Total Payments”) would be subject to the excise tax imposed under Section 4999
of the Internal Revenue Code of 1986, as amended (the “Code”), then the Total Payments shall be reduced (but
not below zero) so that the maximum amount of the Total Payments (after reduction) shall be one dollar ($1.00) less than the amount
which would cause the Total Payments to be subject to the excise tax imposed by Section 4999 of the Code, but only if the Total
Payments so reduced result in the Executive receiving a net after tax amount that exceeds the net after tax amount the Executive
would receive if the Total Payments were not reduced and were instead subject to the excise tax imposed on excess parachute payments
by Section 4999 of the Code. Unless the Executive shall have given prior written notice to the Company to effectuate a reduction
in the Total Payments if such a reduction is required, any such notice consistent with the requirements of Section 409A of the
Code to avoid the imputation of any tax, penalty or interest thereunder, the Company shall reduce or eliminate the Total Payments
by first reducing or eliminating any cash severance benefits (with the payments to be made furthest in the future being reduced
first), then by reducing or eliminating any accelerated vesting of stock options or similar awards, then by reducing or eliminating
any accelerated vesting of restricted stock or similar awards, then by reducing or eliminating any other remaining Total Payments.
The preceding provisions of this Section 7(a) shall take precedence over the provisions of any other plan, arrangement or agreement
governing the Executive’s rights and entitlements to any benefits or compensation.


 


(b) If
the Total Payments to the Executive are reduced in accordance with Section 7(a), as a result of the uncertainty in the application
of Section 4999 of the Code at the time of the initial reduction under Section 7(a), it is possible that Total Payments to the
Executive which will not have been made by the Company should have been made (“Underpayment”) or that Total
Payments to the Executive which were made should not have been made (“Overpayment”). If an Underpayment has
occurred, the amount of any such Underpayment shall be promptly paid by the Company to or for the benefit of the Executive. In
the event of an Overpayment, then the Executive shall promptly repay to the Company the amount of any such Overpayment together
with interest on such amount (at the same rate as is applied to determine the present value of payments under Section 280G of
the Code or any successor thereto), from the date the reimbursable payment was received by the Executive to the date the same
is repaid to the Company


 






    10


     


    




 


8. Confidentiality
and Restrictive Covenants. 


 


(a) Covenant
Against Disclosure. All Confidential Information (defined below) relating to the Business of the Company and its affiliates
is, shall be and shall remain the sole property and confidential business information of them, free of any rights of the Executive.
The Executive shall not make any use of the Confidential Information except in the performance of his duties hereunder and shall
not disclose any Confidential Information or trade secret to third parties except as required by law, with the limited qualification
that in accordance with the Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly liable under
any Federal or State trade secret law for the disclosure of a trade secret that is made either: (1) in confidence to a Federal,
State, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or
investigating a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit or other proceeding, if
such filing is made under seal, “Confidential Information” includes without limitation such documents as business
plans, source code, documentation, financial analysis, marketing plans, customer names, customer lists, customer data, contracts
and other business information, including the information of the Company and its affiliates, existing or prospective customers,
clients, investors or other third parties with whom the Company and its affiliates hereto have relationships or conduct business
that may be disclosed to the Executive as part of the Executive’s employment. Notwithstanding anything else set forth herein,
nothing in this Agreement shall be construed to prohibit Executive from reporting, without first notifying the Company or otherwise,
possible violations of law or regulation to any governmental agency or entity.


 


(b) Return
of Company Documents. On the Termination Date or on any prior date upon the Company’s written demand, the Executive
will return all Confidential Information in his possession, directly or indirectly, that is in written or other tangible form
(together with all duplicates thereof).


 


(c) Further
Covenant. During the Term and through the first anniversary of the Termination Date, the Executive shall not, directly or
indirectly, take any of the following actions, and, to the extent the Executive owns, manages, operates, controls, is employed
by or participates in the ownership, management, operation or control of, or is connected in any manner with, any business, the
Executive will use his best efforts to ensure that such business does not take any of the following actions:


 


(i) persuade
or attempt to persuade any customer of the Company or its affiliates to cease doing business with the Company or its affiliates,
or to reduce the amount of business any customer does with the Company or its affiliates;


 


(ii) solicit
for himself or any entity the business of a person or entity that was a customer of the Company or its affiliates within the 12
months prior to the termination of the Executive’s employment, in competition with the Company or its affiliates; or


 


(iii) persuade
or attempt to persuade any employee of the Company or its affiliates to leave the employ of the Company or its affiliates, or
hire or engage, directly or indirectly, any individual who was an employee of the Company or its affiliates within 1 year prior
to the Executive’s Termination Date.


 


9. D&O
Insurance.  At the request of the Executive, the Company obtain and continue for as long as Executive is employed by
the Company, directors’ and officers’ insurance coverage at levels no less than $5,000,000 with an insurance company
rated “A” or higher.


 


10. Waiver.
Except with respect to opportunities in which the Company would be interested in the ordinary course of its business and which
are presented to the Executive in his capacity as a director or executive officer of the Company, the  Board has renounced
on behalf of the Company and its shareholders all interest and expectancy to (or being offered any opportunity to participate
in) any opportunity presented to the Executive that may be considered a corporate opportunity of the Company, and the Executive
shall have no obligation to communicate, offer, or present any opportunity presented to the Executive that may be considered a
corporate opportunity of the Company, whether centered on geography, land rights, or otherwise (the “Renouncement”). 
The Company acknowledges that the Renouncement is a material term of this Agreement and the Executive is specifically relying
on the Renouncement in agreeing to enter into this Agreement.  Except with respect to opportunities in which the Company
would be interested in the ordinary course of its business and which are presented to the Executive in his capacity as a director
or executive officer of the Company, to the fullest extent permitted by law, the Company hereby prospectively waives any and all
claims arising from any business transacted by the Executive that could be construed as a corporate opportunity of the Company. 
A copy of the Board resolution is attached hereto as Exhibit B.


 






    11


     


    

 


11. No
Disparagement. During the Term and through the second anniversary of the Termination Date, the Executive will not make public
statements or communications that disparage the Company or any of its businesses, services, products, affiliates or current, former
or future directors and executive officers in their capacity as such. During the Term and through the second anniversary of the
Termination Date, the Company will instruct its directors and executives not to make public statements or communications that
disparage the Executive. The foregoing obligations shall not be violated by truthful statements to any governmental agency or
entity, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation,
depositions in connection with such proceedings).


 


12. Indemnification.
During the Term and thereafter, the Company shall indemnify and hold the Executive and the Executive’s heirs and representatives
harmless, to the maximum extent permitted by law, against any and all damages, costs, liabilities, losses and expenses (including
reasonable attorneys’ fees) as a result of any claim or proceeding (whether civil, criminal, administrative or investigative),
or any threatened claim or proceeding (whether civil, criminal, administrative or investigative), against the Executive that arises
out of or relates to the Executive’s service as an officer, director or employee, as the case may be, of the Company, or
the Executive’s service in any such capacity or similar capacity with any affiliate of the Company or other entity at the
Company’s request, both prior to and after the Effective Date, and to promptly advance to the Executive or the Executive’s
heirs or representatives such expenses, including litigation costs and attorneys’ fees, upon written request with appropriate
documentation of such expense upon receipt of an undertaking by the Executive or on the Executive’s behalf to repay such
amount if it shall ultimately be determined that the Executive is not entitled to be indemnified by the Company. During the Term
and thereafter, the Company also shall provide the Executive with coverage under its then current directors’ and officers’
liability policy to the same extent that it provides such coverage to its other executive officers. If the Executive has any knowledge
of any actual or threatened action, suit or proceeding, whether civil, criminal, administrative or investigative, as to which
the Executive may request indemnity under this provision, the Executive will give the Company prompt written notice thereof; provided
that the failure to give such notice shall not affect the Executive’s right to indemnification. The Company shall be entitled
to assume the defense of any such proceeding and the Executive will use reasonable efforts to cooperate with such defense. To
the extent that the Executive in good faith determines that there is an actual or potential conflict of interest between the Company
and the Executive in connection with the defense of a proceeding, the Executive shall so notify the Company and shall be entitled
to separate representation at the Company’s expense by counsel selected by the Executive (provided that the Company may
reasonably object to the selection of counsel within 10 business days after notification thereof) which counsel shall cooperate,
and coordinate the defense, with the Company’s counsel and minimize the expense of such separate representation to the extent
consistent with the Executive’s separate defense. This Section 12 shall continue in effect after the termination of the
Executive’s employment or the termination of this Agreement


 


13. Disputes.


 


(a) Any
dispute or controversy arising out of or relating to this Agreement or your employment shall be brought solely in the state and
federal courts located in the State and County of New York.


 






    12


     


    

 


(b) BOTH
THE COMPANY AND THE EXECUTIVE HEREBY WAIVE ANY RIGHT TO A TRIAL BY JURY TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE FEDERAL
OR STATE LAW.


 


(c) In
the event of any contest or dispute relating to this Agreement or the termination of Executive’s employment hereunder, the
non-prevailing party in any such contest or dispute shall be liable for the attorneys’ fees and costs of the prevailing
party.


 


14. Integration.
This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all
prior agreements between the parties concerning such subject matter.


 


15. Successors.
This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal representatives, executors,
administrators, heirs, distributees, devisees and legatees. In the event of the Executive’s death after his termination
of employment but prior to the completion by the Company of all payments due him under this Agreement, the Company shall continue
such payments to the Executive’s beneficiary designated in writing to the Company prior to his death (or to his estate,
if the Executive fails to make such designation). The Company shall require any successor to the Company to expressly assume and
agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if
no such succession had taken place.


 


16. Enforceability.
If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this
Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of
this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared
illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable
to the fullest extent permitted by law.


 


17. Survival.
The provisions of this Agreement shall survive the termination of this Agreement or the termination of the Executive’s employment
to the extent necessary to effectuate the terms contained herein.


 


18. Waiver.
No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any
party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this
Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.


 


19. Notices.
Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered
in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return
receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of
the Company, at its main offices,


 


	 	If to Executive:	Theodore Farnsworth




444
Brickell Avenue 


Miami
Florida 33131


 


	 	If to Company:	Helios and Matheson Analytics Inc.




350
5th Ave - Ste 7520 


New
York, NY 10118 


Attention:
CFO


 






    13


     


    

 


20. Amendment.
This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized representative
of the Company.


 


21. Governing
Law. This is a New York contract and shall be construed under and be governed in all respects by the laws of New York for
contracts to be performed in that State and without giving effect to the conflict of laws principles of New York or any other
State.


 


22. Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be
an original; but such counterparts shall together constitute one and the same document.


 


[REMAINDER
OF THIS PAGE LEFT INTENTIONALLY BLANK]








 






    14


     


    

 


IN
WITNESS WHEREOF, the parties have executed this Agreement effective on the date and year first above written.


 





	 	HELIOS
    AND MATHESON ANALYTICS INC.
	 	 	 
	 	By:	/s/
    Stuart Benson
	 	Name:	Stuart
    Benson
	 	Title:	Chief
    Financial Officer
	 	 	 
	 	THEODORE
    FARNSWORTH 
	 	 
	 	/s/
    Theodore Farnsworth




 



    15


     


    

 


Exhibit
A


 


Initial
Award 


 


As of the Effective Date,
the Company shall grant to the Executive 2,000,000 shares of common stock (subject to proportionate adjustment for any stock split
or combination or other recapitalization event), subject to the terms of the applicable Award Agreement. The shares shall vest
in their entirety on February 15, 2019, which is 18 months following August 15, 2017, the date on which the Company entered into
a Securities Purchase Agreement to acquire a majority stake in MoviePass Inc. (the “MoviePass SPA”), which requires
that the Company enter into a 5-year employment agreement with the Executive prior to the closing under the MoviePass SPA. 


 


Treatment
resulting from termination of employment 


 


	Death or Disability	 	All unvested award shares immediately vest on the applicable Termination Date.
	 	 	 
	Voluntary quit	 	All unvested award shares that did not yet vest will be cancelled on the last day of employment.
	 	 	 
	Termination for Cause	 	All unvested award shares that did not yet vest will be cancelled on the last day of employment.
	 	 	 
	Termination without Cause/ Quit for Good Reason	 	All unvested award shares immediately vest on the applicable Termination Date.






 


The
terms of any award under this Exhibit A shall be more fully set forth in an Award Agreement. It is expressly acknowledged and
agreed that this Exhibit A is a summary of the contemplated terms of the applicable Award Agreement, which shall be subject to
the Company’s receipt of all corporate approvals required by applicable law or the rules and regulations of the Principal
Market prior to effectiveness thereof. To the extent that there is any conflict between the terms of this Exhibit A and the applicable
Award Agreement, the terms of the Award Agreement shall govern.


 









    16


     


    

 


Exhibit
B


 


(Board
Resolutions for Prospective Waiver of Corporate Opportunities)


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 






    17


     


    

 


SCHEDULE
1


 


Market
Capitalization Milestones


 


If
the Company’s common stock is publicly traded during the Term and the market capitalization of the Company is for 20 consecutive
trading days during the Term at or above the following milestones, the Executive shall receive, within five business days following
such 20th consecutive trading day, an award of shares of Company common stock (a) which shall vest upon the later of February
15, 2019 and the end of the applicable three-month period following the applicable date of the grant, and (b) that, upon the date
of the grant, shall have an aggregate value equal the percentage of the market capitalization set forth next to the applicable
milestone* below based on the closing price of the common stock on the Principal Market on the date of the grant (the “Fair
Market Value”):


 





	Company 
Market Capitalization Milestone	 	Percentage
	$100,000,000	 	3%
	$150,000,000	 	3%
	$200,000,000	 	4%
	$250,000,000	 	4%
	$300,000,000	 	5%
	$350,000,000	 	5%
	$400,000,000	 	7%
	$450,000,000	 	7%
	$500,000,000	 	9%
	every additional $100,000,000 thereafter (cumulated with the applicable immediately preceding milestone)	 	10%






 


Each
milestone above is a separate milestone for which the Executive may earn the applicable percentage. The Executive will be entitled
to earn the applicable percentage for each milestone only once. The Company’s market capitalization for each applicable
milestone and measurement period will be determined based on the market capitalization reported by Bloomberg LP. 


 


*
For example:


 


If
the Company’s market capitalization is at least $250,000,000 as of market close for at least 20 consecutive trading days
and the Fair Market Value is $12.50 per share, Executive shall receive 800,000 fully vested shares of common stock of the Company
(800,000 *$12.50 = $10,000,000 which is 4% of $250,000,000).


 


The
terms of any award under this Schedule 1 shall be more fully set forth in an Award Agreement. It is expressly acknowledged and
agreed that this Schedule 1 is a summary of certain contemplated terms of the applicable Award Agreement, which shall be subject
to the Company’s receipt of all corporate approvals required by applicable law or the rules and regulations of the Principal
Market prior to effectiveness thereof. To the extent that there is any conflict between the terms of this Schedule 1 and the applicable
Award Agreement, the terms of the Award Agreement shall govern.


 


 


18